Skip to Main Content

Alfred Chung



Dr. Alfred Chung is a hematologist-oncologist who cares for patients with blood cancers, including leukemias, lymphomas and myelomas. He sees patients who are in the hospital for treatment, including those who need a bone marrow transplant and those receiving chemotherapy or cellular therapies to bolster the immune system.

Chung's research centers on the study and development of new therapies for plasma cell disorders, including multiple myeloma and amyloidosis (buildup of an abnormal protein called amyloid in the organs). One specific area of study is light chain amyloidosis, in which the dysfunction of certain antibody-producing cells results in abnormal protein fibers in the organs. Chung is looking specifically at targeted therapies to treat this type of amyloidosis as well as novel therapeutic strategies in the treatment of multiple myeloma.

After earning a bachelor's degree in chemical engineering at the University of Michigan, Chung earned a medical degree at Northwestern University Feinberg School of Medicine. At Stanford Medicine, he completed a residency in internal medicine, followed by a fellowship in hematology and oncology.

Chung is a member of the American Society of Clinical Oncology, American Society of Hematology and Association of Northern California Oncologists.

  • Education

    Feinberg School of Medicine, MD, 2014

  • Residencies

    Stanford Medicine, Internal Medicine, 2017

  • Fellowships

    Stanford Medicine, Hematology and Oncology, 2020

  • Academic Title

    Assistant Professor

My reviews


Overall Experience
230 Ratings
About our process
Jun 24, 2023
Great meeting
Jun 22, 2023
I have multiple myeloma and have much difficulty in hearing. I am scare of dying. Dr. Chung speaks loudly clearly so I can participate in the conversation. Dr. Chung Is very careful in preparing me for the bone marrow transplant (BMT) process such as providing referrals to visit necessary specialists such as geriatric drug allergies etc prior to BMT. I so appreciate Dr. Chung's recommendations that I need to gain weight and exercise. I also appreciate Dr. Chung's straight forward comments that I will feel a lot worse in the process compare to how I feel now. This is so important to me because it gives me a head up of how important it is for me to eat well and commit to exercise every day.
Jun 08, 2023
Dr. Alfred Chung is the best doctor I have ever seen. He is very knowledgeable friendly professional experience with a lot expertise.
Apr 08, 2023
On time great explanation and MyChart appointments are fantastic.
Mar 13, 2023
Dr. Alfred Chung is excellent. He is very knowledgeable professional passionate and hard working physician an asset of UCSF
Mar 09, 2023
Dr. Is very knowledgeable
Feb 28, 2023
Very helpful during stressful time in my life.
Jan 11, 2023
All the way around excellent. Explained everything in language we could understand took time to answer any questions extremely experienced and knowledgeable about the conditions involved.
Jan 11, 2023
Dr. Chung is a fantastic professional
Dec 07, 2022
I am alive because of UCSF.
Nov 10, 2022
Doctor after all we have been through together has become what I consider a trusted friend.
Nov 06, 2022
Dr. Chung was great!
Oct 19, 2022
It was my first visit to Dr. Chung (I may have spoken to him once in the very early days of my treatment.) and he was very attentive. He listened to everything I wanted to talk about gave me feedback and covered everything he needed to tell me. I was very happy with my visit.
Sep 30, 2022
Dr. Chung is a fantastic professional in all regards.
Sep 28, 2022
Care provider was very professional and described variants of my condition such that I understood underlying causes and manifestations of present health condition.
Sep 26, 2022
Super great experience extremely informative and explain the possible treatment.
Sep 24, 2022
Dr Chung was outstanding. He listened to me shared so much information and made it easy to understand. While discussing a scary potential disease he presented it with kindness knowledge and hope. I left the appointment feeling so much better and feeling like with Dr Chung on my team I will be more than ok!!!
Jul 27, 2022
Dr Chung has a lot of patience and listens well to my questions and concern. I am very comfortable with him and I appreciate him for being my doctor.
Jul 06, 2022
Excellent discussion and advice
Jun 02, 2022
I am very happy about my medical care with this provider.
May 19, 2022
Friendly courteous knowledgeable about my condition.
Mar 16, 2022
Dr. Chung is very thorough compassionate and very good in explaining a very complicated situation to any late person such as myself. I would highly recommend him to anyone
Mar 05, 2022
Dr. Chung is managing my induction chemotherapy for cancer. Had to recommend him to others.
Feb 12, 2022
Dr. Chung seems much more friendly and relaxed than in prior visits. Very happy about that. Compassion optimism and connection are very important to patients - those traits despite the rigor of the profession should always be in focus during clinic visits.
Feb 03, 2022
Really appreciate Dr. Chung. Nice to see a Myeloma specialist.
Dec 13, 2021
After-visit instructions are very clear; his office subsequently called and we scheduled a follow up appointment within 1 day
Nov 23, 2021
Very through and unhurried
Oct 23, 2021
Dr. Chung is one of the best medical providers that I have ever encountered.
Each patient has a unique story and perspective. I am committed to providing compassionate medical care to people of all backgrounds.

Where I see patients (1)

    Decorative Caduceus

    Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-...

    The International Myeloma Working Group (IMWG) uniform response criteria will be used to assess disease response and progression. The response rate is defined as the proportion of patients achieving a partial response (PR), very g...


    Decorative Caduceus

    A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

    Treatment-emergent adverse events (AEs), treatment-related AEs, and clinically significant changes in laboratory test results will be evaluated